Griffin Stephen D. (CIK 1831125) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-05). Recent activity: Buy ANIK (12,840 shares), Sell ANIK (3,769 shares), Buy ANIK (12,200 shares), Buy ANIK (12,824 shares), Buy ANIK (6,412 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-05 | Anika Therapeutics, Inc. (ANIK) | President and CEO | Buy | 12,840 | $0 |
| 2026-06-05 | Anika Therapeutics, Inc. (ANIK) | President and CEO | Sell | 3,769 | $54,311 |
| 2026-04-30 | Anika Therapeutics, Inc. (ANIK) | President and CEO | Buy | 12,200 | $149,881 |
| 2026-03-17 | Anika Therapeutics, Inc. (ANIK) | President and CEO | Buy | 12,824 | $0 |
| 2026-03-17 | Anika Therapeutics, Inc. (ANIK) | President and CEO | Buy | 6,412 | $0 |
| 2026-03-17 | Anika Therapeutics, Inc. (ANIK) | President and CEO | Sell | 5,944 | $84,405 |
| 2025-06-05 | Anika Therapeutics, Inc. (ANIK) | EVP, CFO & COO | Buy | 12,840 | $0 |
| 2025-06-05 | Anika Therapeutics, Inc. (ANIK) | EVP, CFO & COO | Sell | 3,769 | $43,683 |
Source: SEC Form 4 filings · as of 2026-06-05